Trial Profile
A Randomized, Placebo-Controlled, 3-way Crossover Study to Investigate the Pharmacodynamic Effects of ICA-105665 Using the Intradermal Capsaicin and UV-B Models in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs ICA 105665 (Primary) ; Ibuprofen
- Indications Pain
- Focus Pharmacodynamics
- Sponsors Neusentis
- 07 Jul 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 04 Mar 2010 Status changed from recruiting to completed, according to an Icagen media release.
- 04 Mar 2010 Results were reported in a Icagen media release.